Bone marrow stem cells transplantation improve locomotive function of dystrophin/utrophin gene double knock-out mice.
- Author:
Cheng ZHANG
1
;
Song-lin CHEN
;
Xiao-rong LIU
;
Wen HUANG
;
Wei-xi ZHANG
;
Xi-lin LU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Cytoskeletal Proteins; biosynthesis; deficiency; genetics; Dystrophin; deficiency; genetics; Hematopoietic Stem Cell Transplantation; Membrane Proteins; biosynthesis; genetics; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscular Dystrophy, Duchenne; physiopathology; surgery; Utrophin
- From: Acta Academiae Medicinae Sinicae 2003;25(2):160-163
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEStudy the improvement of locomotive faculty of dystrophin/utropin gene double knock-out mice (dko mice) by transplanting bone marrow stem cells.
METHODSThe bone marrow stem cells of C57BL/6 mice (4- to 5-weeks age) were cultured in vitro for three days, before transplanted intravenously (1.0 x 10(7) for each) into 11 dko mice (7- to 8-weeks age). The dko mice were irridiated with 7Gy gamma-ray before transplantation. 8-9 weeks after transplantation, the locomotroy function, electromyography items and expression of dystrophin in transplanted mice and controls were observed.
RESULTS8-9 weeks after transplantation, the dropping times of hauling wire were 3.09 +/- 2.47, compared with that of the control dko mice(16.78 +/- 3.60), there are distinct differences. About electromyography items, the duration of active potential and amplitude of maxim contractions were (4.99 +/- 1.62) ms and(2872 +/- 1474.33) microV, compare with those of control dko mice(3.69 +/- 0.40) ms and(1210.0 +/- 551.0) microV, respectively, about 7% fibers of the muscle tissue of transplanted dko mice expressed dystrophin protein.
CONCLUSIONS8-9 weeks after transplanted with homology bone marrow stem cells, the locomotive function and electromyography items of transplanted dko mice were obviously improved, and about 7% muscle tissue fibers of the mice expressing dystrophin protein were observed. It suggested that there is an ideal prospect for DMD therapy with bone marrow stem cells transplantation.